Looking back at his 10-years in myopia management, Dr. Neukirch cites the most significant event that influenced this segment of his practice: the 2019 FDA approval* of MiSight® 1 day contact lenses to slow the progression of myopia1 in children aged 8-12 at the initiation of treatment.